Skip to content

Clinical trials

Completed Phase 2 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 2 Status: Completed Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20032
20046
200511
200610
200712
20086
200911
201013
20113
20125
20133
20146
20152
20164
20174
20183
20192
20203
20213
20222
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)19
Medical University of South Carolina11
Yale University10
University of Chicago7
Johns Hopkins University6
New York State Psychiatric Institute6
VA Office of Research and Development5
San Francisco Department of Public Health3
University of California, Los Angeles3
University of Pennsylvania3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders149
Cocaine-Related Disorders28
Opioid-Related Disorders28
Alcoholism21
Stress Disorders, Post-Traumatic9
HIV Infections8
Alcohol-Related Disorders5
Mental Disorders5
Heroin Dependence4
Marijuana Abuse4

Trials

Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.